1. MEAT (Most Economically Advantageous Tendering) - Ensuring Recognition for the Value of Innovation
BELEN MARTI - Iberia Market Access
CRISTINA NUNES - Market Access & Health Economics – LATAM
Toronto Oct 17th 2017

2. Situation “New” European Policy on Public Procurement:
Concept of purchasing considering Most Economically Advantageous Tendering and Value.
Medtech Europe is partnering with Purchasing and Hospital/Regional stakeholders.
Edwards BUs and cross functional teams:
WG to understand and best shape and influence the evolution of MEAT.
THV - Nathan Petersen; HVT - Jacky Amar; CC - Olga Quejido; Legal - Ennio Marengo; B&T - Martin Nozicka; MA - Gordon Goodall & Belén Martí

3. Value Based Healthcare & Value Based procurement
Outcome
Cost
HC Value =
Socio-economic
impact
Innovation
Sustainability
Patient
HCP
Health
system
Provider
Outcomes
Costs
incl. care delivery
Central goal in health care becomes value for the patient
*M. Porter: Redefining Health Care, 2006
*"Redefining Healthcare", BCG analysis

4. Actions Current status of the EU Directive and MEAT.
Experimenter’s feedback in countries piloting the tool (TAVI – H Clinic, SP).
Session HC employees and consulting firms.

5. Results
Educate key stakeholders at Edwards EMEA: New directive and potential opportunity.
Adoption of the Value of Medical Technology is spreading worldwide.

6. Ensuring Value of Innovation
Policies “allowing” adoption of Value
Opportunities and barriers
Definition
Value of our technologies are adequately assessed. 

7. Cross Geography Situation: MEAT application: Brazilian payer
There are not reimbursement in the most Latin America countries for some EDW products
The payers have a little knowledge about health economics
GAP between the prices (EDW vs Competitors)
MEAT application:
Brazilian payer
Health Plan with own hospitals
Argentina
Payer focused in elderly
Mexico with Integrator
Companies that sell the procedure package
Colombia
Payers that choice the hospitals by the package
VALUE